Wikidata entity: Q5908266
C₂₂H₁₈FN₇O (P274)
Quantities
| P2067 | mass | 415.156 |
| P3780 | active ingredient in | ... | Q29006763 (Zydelig) | Zydelig |
| P233 | canonical SMILES | String | CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 | ??? |
| P373 | Commons category | String | Idelalisib | ??? |
| P703 | found in taxon | ... | Q6845785 (Bletilla formosana) | Bletilla formosana |
| P703 | found in taxon | ... | Q42550590 (Laurencia tristicha) | Laurencia tristicha |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284515 (LiverTox toxicity likelihood category D) | LiverTox toxicity likelihood category D |
| P2175 | medical condition treated | ... | Q208414 (lymphoma) | lymphoma |
| P2175 | medical condition treated | ... | Q268713 (mantle cell lymphoma) | mantle cell lymphoma |
| P2175 | medical condition treated | ... | Q1088156 (chronic lymphocytic leukemia) | chronic lymphocytic leukemia |
| P2175 | medical condition treated | ... | Q1138590 (non-Hodgkin lymphoma) | non-Hodgkin lymphoma |
| P2175 | medical condition treated | ... | Q1778287 (Waldenström macroglobulinemia) | Waldenström macroglobulinemia |
| P2175 | medical condition treated | ... | Q2626074 (diffuse large B-cell lymphoma) | diffuse large B-cell lymphoma |
| P2175 | medical condition treated | ... | Q4833719 (B-cell lymphoma) | B-cell lymphoma |
| P129 | physically interacts with | ... | Q7117823 (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| P129 | physically interacts with | ... | Q7117825 (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta) | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
| P129 | physically interacts with | ... | Q21115992 (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
| P129 | physically interacts with | ... | Q21123236 (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma) | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q177094 (imatinib) | imatinib |
| P769 | significant drug interaction | ... | Q419186 (ergotamine) | ergotamine |
| P769 | significant drug interaction | ... | Q421052 (everolimus) | everolimus |
| P769 | significant drug interaction | ... | Q421136 (sorafenib) | sorafenib |
| P769 | significant drug interaction | ... | Q408977 (vincristine) | vincristine |
| P769 | significant drug interaction | ... | Q412197 (irinotecan) | irinotecan |
| P769 | significant drug interaction | ... | Q412327 (nilotinib) | nilotinib |
| P769 | significant drug interaction | ... | Q423762 (paclitaxel) | paclitaxel |
| P769 | significant drug interaction | ... | Q670131 (simvastatin) | simvastatin |
| P769 | significant drug interaction | ... | Q795057 (cabozantinib) | cabozantinib |
| P769 | significant drug interaction | ... | Q894611 (bosutinib) | bosutinib |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q5984881 (ibrutinib) | ibrutinib |
| P769 | significant drug interaction | ... | Q412963 (cabazitaxel) | cabazitaxel |
| P769 | significant drug interaction | ... | Q417542 (sunitinib) | sunitinib |
| P769 | significant drug interaction | ... | Q417915 (sufentanil) | sufentanil |
| P769 | significant drug interaction | ... | Q7157043 (pazopanib) | pazopanib |
| P769 | significant drug interaction | ... | Q7383611 (ruxolitinib) | ruxolitinib |
| P769 | significant drug interaction | ... | Q7699074 (temsirolimus) | temsirolimus |
| P769 | significant drug interaction | ... | Q21011233 (ceritinib) | ceritinib |
| P769 | significant drug interaction | ... | Q27126905 (docetaxel trihydrate) | docetaxel trihydrate |
| P769 | significant drug interaction | ... | Q27139135 (dasatinib monohydrate) | dasatinib monohydrate |
| P769 | significant drug interaction | ... | Q3011604 (dabrafenib) | dabrafenib |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2868 | subject has role | ... | Q2853144 (antineoplastic) | antineoplastic |
Why not click here or view trends?
log id: 1928202